Category: Pharmacotherapy and Experimental Therapeutics
DPET Fellow Kevin Brown Earns Rho Chi Scholarship
March 6, 2008Kevin Brown, PharmD, an Academic HIV Pharmacology Fellow at the UNC School of Pharmacy, has been selected as the recipient of the Rho Chi Research Scholarship. Brown will receive the award during the Rho Chi Annual Meeting on Sunday, March 16, in San Diego, California. He will receive $7,500 to be used for fellowship funding or research costs during the second year of his fellowship. Rho Chi will also reimburse up to $500 of expenses incurred for attending the annual meeting. The scholarship was established in 2003, and only one is awarded each year to a member of the Rho … Read more
Zamboni Joins School of Pharmacy, Lineberger
March 3, 2008William Zamboni, PharmD, PhD, an expert in translational studies of anticancer agents, has joined the UNC School of Pharmacy and the UNC Lineberger Comprehensive Cancer Center. Zamboni, who came to UNC from the University of Pittsburgh, is an associate professor in the School’s Division of Pharmacotherapy and Experimental Therapeutics. He is also a member of the School’s Institute for Pharmacogenomics and Individualized Therapy and an associate member at Lineberger. “Dr. Zamboni brings an international reputation in cancer clinical pharmacology and will make a big impact on the development of new therapies for the patients of North Carolina,” says Howard McLeod, … Read more
2008 Graduate Student Awards
January 27, 2008The UNC Eshelman School of Pharmacy held its Graduate Achievement Banquet on January 26. UNC-CH Graduate School Scholarships Two first-year doctoral students from the School were recipients of merit assistantships. The UNC Graduate School awards merit assistantships to promising incoming graduate students, with the objective of maintaining and increasing the quality of graduate students at UNC-Chapel Hill. The School’s recipients are: Beth Vasiveich, Division of Molecular Pharmaceutics Christina Won, Division of Pharmacotherapy and Experimental Therapeutics The UNC Graduate School also awards a few competitive merit fellowships each year to incoming graduate students with exceptional potential. The Royster Society of Fellows … Read more
Hoskins to Direct UNC Genomics Facility
January 15, 2008The UNC Institute for Pharmacogenomics and Individualized Therapy, a research center within the UNC School of Pharmacy, recently named Janelle M. Hoskins as the director of its new Molecular Genomics Facility. This facility provides project design, data analysis, technology selection, and genotyping for IPIT investigators. A native of Australia, Hoskins received her PhD in pharmacology at the University of Sydney and postdoctoral training at Washington University School of Medicine in St. Louis and at UNC-Chapel Hill. Hoskins is an expert in the pharmacogenetics of metabolizing enzymes and drug transporters with more than twenty scientific papers published in international peer-reviewed journals … Read more
Brouwer Receives Award from Alma Mater
December 11, 2007Kim Brouwer, PhD, the George H. Cocolas Distinguished Professor at the UNC School of Pharmacy, has received the Paul F. Parker Award from the University of Kentucky and the American Society of Health-System Pharmacists. The annual honor recognizes a former resident of the UK Pharmacy Residency Program or someone intimately associated with the success of the program for the individual’s contribution to the profession via teaching or research. Recipients must show commitment to high ideals and excellence in their chosen field and encourage the personal and professional growth of others. Brouwer, who chairs the Division of Pharmacotherapy and Experimental Therapeutics, … Read more
Patterson Promoted to Full Professor
December 1, 2007The UNC School of Pharmacy has promoted J. Herbert Patterson, PharmD, FCCP, to full professor. Patterson joined the School in 1981. He has been an associate professor since 1988 and currently serves as the vice chair of the School’s Division of Pharmacotherapy and Experimental Therapeutics, where he also directs the division’s graduate program. Patterson holds a joint appointment as a research associate professor in the Division of Cardiology at the UNC School of Medicine, and he has served as co-chair of the UNC Biomedical Institutional Review Board since March 2005. Patterson received his bachelor’s and doctor of pharmacy degrees from … Read more
UNC Students to Present Posters at AAPS Annual Meeting
November 7, 2007Students from the UNC School of Pharmacy will present posters at the American Association of Pharmaceutical Scientists Annual Meetings and Expositions at the San Diego Convention Center on November 13-14. The students are: Koji Abe, PhD — Visiting Scholar Faculty adviser: Kim Brouwer, PhD Division: Pharmacotherapy and Experimental Therapeutics Title of Abstract: “In Vitro Biliary Clearance of Angiotensin II Receptor Blockers and HMG-CoA Reductase Inhibitors in Sandwich-Cultured Rat Hepatocytes — Comparison to In Vivo Biliary Clearance” Session Date: Tuesday, November 13 Session Time: 1:00-5:00 p.m. Location: Exhibit Hall Dan Bow, PhD Faculty adviser: Kim Brouwer, PhD Division: Pharmacotherapy and Experimental … Read more
Abdelnaser Rezk Promoted to Research Assistant Professor
October 18, 2007The UNC School of Pharmacy has promoted Abdelnaser Rezk, PhD, to research assistant professor. Rezk has been working as a research associate and research instructor in the School’sDivision of Pharmacotherapy and Experimental Pharmaceutics since 2004. He also is a research associate and associate director for the Clinical Pharmacology and Analytical Chemistry Core at the UNC Center for AIDS Research, as well as the Verne S. Caviness General Clinical Research Center Analytical Chemistry Laboratory. Rezk develops ways to measure drugs and metabolites in biological fluids to answer important questions in the treatment of HIV/AIDS and other diseases. The data he generates … Read more
IPIT Study Questions FDA Genetic-Screening Guidelines for Cancer Drug
August 27, 2007Not everyone needs a genetic test before taking the cancer drug irinotecan, and the U.S. Food and Drug Administration should modify its prescription guidelines to say so, according to researchers at the University of North Carolina at Chapel Hill. Irinotecan, also known by its brand name Camptosar, is used mainly as a second-line treatment for colorectal cancer. The FDA recommends screening patients for a gene that could make them more susceptible to the harmful side effects of the drug, the most worrisome of which is neutropenia, an abnormally low number of white blood cells. In a paper published in the … Read more
Craig Lee Receives Grant from American Heart Association
July 17, 2007Craig Lee, PhD, an assistant professor at the UNC School of Pharmacy, has received a $132,000 beginning grant-in-aid from the American Heart Association. Lee will use the two-year grant, titled “P450 Epoxygenase Pathway and Atherosclerotic Cardiovascular Disease”, to study the relationship between genetic variation in the cytochrome P450 epoxygenase pathway and mechanisms underlying the risk of cardiovascular disease. Cytochromes P450 are a metabolic enzyme family present throughout the body. The pathway Lee is studying is active in the cardiovascular system and forms epoxyeicosatrienoic acids (also known as EETs), which dilate blood vessels and have anti-inflammatory effects. About ten to twenty-five … Read more